Anavex Life Sciences Corporation.

AVXL·NASDAQ·$2.71Share Price as of 11/2·$251MMarket Cap as of 11/2

Financials

10-K/AFY 202508/28/26 10-QQ3 ended 06/30/2608/28/26 10-QQ2 ended 03/31/2608/28/26 10-Q/AQ1 ended 12/31/2508/28/26 10-QQ1 ended 12/31/2502/09/26

Disclosures

8-KCurrent report10/20/26 8-KCurrent report10/15/26 8-KCurrent report09/28/26 8-KCurrent report09/09/26 8-KCurrent report09/02/26

Prospectuses and Registrations

424B5Prospectus supplement07/25/25 S-3Shelf registration07/14/25 S-3Shelf registration07/29/24 424B5Prospectus supplement02/07/23 S-8Registration of securities for employees06/10/22

Proxies

DFAN14AAdditional materials (non-management)09/21/26 DFAN14AAdditional materials (non-management)09/18/26 DFAN14AAdditional materials (non-management)09/17/26 DEFA14AAdditional proxy materials09/15/26 DFAN14AAdditional materials (non-management)09/15/26

Ownership

Form 3Initial insider ownership10/05/26 Form 3Initial insider ownership10/05/26 Form 4Insider transaction09/28/26 SC 13GBeneficial ownership07/31/26 Form 3Initial insider ownership05/14/26

Other

NT 10-QLate filing notification (10-Q)08/10/26 NT 10-QLate filing notification (10-Q)05/11/26 EFFECTRequest for effectiveness07/23/25 CORRESPCorrespondence with the SEC07/21/25 UPLOADLetter from the SEC07/21/25